These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19451594)

  • 1. In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues.
    Wang W; Rayburn ER; Velu SE; Nadkarni DH; Murugesan S; Zhang R
    Clin Cancer Res; 2009 May; 15(10):3511-8. PubMed ID: 19451594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action.
    Wang W; Rayburn ER; Velu SE; Chen D; Nadkarni DH; Murugesan S; Chen D; Zhang R
    Breast Cancer Res Treat; 2010 Sep; 123(2):321-31. PubMed ID: 19936915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental therapy of ovarian cancer with synthetic makaluvamine analog: in vitro and in vivo anticancer activity and molecular mechanisms of action.
    Chen T; Xu Y; Guo H; Liu Y; Hu P; Yang X; Li X; Ge S; Velu SE; Nadkarni DH; Wang W; Zhang R; Wang H
    PLoS One; 2011; 6(6):e20729. PubMed ID: 21673964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of anticancer efficacy and pharmacological properties of FBA-TPQ, a novel synthetic makaluvamine analog.
    Zhang X; Xu H; Zhang X; Voruganti S; Murugesan S; Nadkarni DH; Velu SE; Wang MH; Wang W; Zhang R
    Mar Drugs; 2012 May; 10(5):1138-1155. PubMed ID: 22822362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer.
    Wang F; Ezell SJ; Zhang Y; Wang W; Rayburn ER; Nadkarni DH; Murugesan S; Velu SE; Zhang R
    Invest New Drugs; 2010 Jun; 28(3):234-41. PubMed ID: 19274441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro anti-lung cancer activity of novel 1, 3, 4, 8-tetrahydropyrrolo [4, 3, 2-de]quinolin-8(1H)-one alkaloid analogs.
    Nadkarni DH; Wang F; Wang W; Rayburn ER; Ezell SJ; Murugesan S; Velu SE; Zhang R
    Med Chem; 2009 May; 5(3):227-36. PubMed ID: 19442212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the ZAK-MKK4-JNK-TGFβ signaling pathway as a molecular target for novel synthetic iminoquinone anticancer compound BA-TPQ.
    Chen D; Wang W; Qin JJ; Wang MH; Murugesan S; Nadkarni DH; Velu SE; Wang H; Zhang R
    Curr Cancer Drug Targets; 2013 Jul; 13(6):651-60. PubMed ID: 23607596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agent.
    Ezell SJ; Li H; Xu H; Zhang X; Gurpinar E; Zhang X; Rayburn ER; Sommers CI; Yang X; Velu SE; Wang W; Zhang R
    Mar Drugs; 2010 Jul; 8(7):2129-41. PubMed ID: 20714427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.
    Tsai SL; Suk FM; Wang CI; Liu DZ; Hou WC; Lin PJ; Hung LF; Liang YC
    Biochem Pharmacol; 2007 Dec; 74(11):1575-86. PubMed ID: 17869226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and pharmacological evaluation of new 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one derivatives as potential antitumor agents.
    Kuang WB; Huang RZ; Qin JL; Lu X; Qin QP; Zou BQ; Chen ZF; Liang H; Zhang Y
    Eur J Med Chem; 2018 Sep; 157():139-150. PubMed ID: 30092368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of anticancer activities of Poria cocos ethanol extract in breast cancer: In vivo and in vitro, identification and mechanism.
    Jiang Y; Fan L
    J Ethnopharmacol; 2020 Jul; 257():112851. PubMed ID: 32283190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
    Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
    Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo.
    Carrasco E; Álvarez PJ; Melguizo C; Prados J; Álvarez-Manzaneda E; Chahboun R; Messouri I; Vázquez-Vázquez MI; Aránega A; Rodríguez-Serrano F
    Eur J Med Chem; 2014 May; 79():1-12. PubMed ID: 24704691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 3-phenylquinolinylchalcone derivatives as potent and selective anticancer agents against breast cancers.
    Tseng CH; Tzeng CC; Hsu CY; Cheng CM; Yang CN; Chen YL
    Eur J Med Chem; 2015 Jun; 97():306-19. PubMed ID: 26005780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis.
    Du J; Sun Y; Lu YY; Lau E; Zhao M; Zhou QM; Su SB
    Anticancer Res; 2017 Nov; 37(11):6141-6151. PubMed ID: 29061795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
    Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
    Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer.
    Srirangam A; Mitra R; Wang M; Gorski JC; Badve S; Baldridge L; Hamilton J; Kishimoto H; Hawes J; Li L; Orschell CM; Srour EF; Blum JS; Donner D; Sledge GW; Nakshatri H; Potter DA
    Clin Cancer Res; 2006 Mar; 12(6):1883-96. PubMed ID: 16551874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Furanodiene, a natural product, inhibits breast cancer growth both in vitro and in vivo.
    Zhong Z; Dang Y; Yuan X; Guo W; Li Y; Tan W; Cui J; Lu J; Zhang Q; Chen X; Wang Y
    Cell Physiol Biochem; 2012; 30(3):778-90. PubMed ID: 22854281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004):
    Mishra CB; Mongre RK; Prakash A; Jeon R; Supuran CT; Lee MS
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):954-963. PubMed ID: 33947294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.